Jan 14 (Reuters) - Eli Lilly ( LLY ) on Tuesday forecast
2025 revenue between $58 billion and $61 billion, on the back of
strong demand for its popular diabetes and weight-loss
medicines.
Analysts were expecting revenue of $58.52 billion, according
to data compiled by LSEG.